Ariad Pharmaceuticals Inc. (ARIA) was a big mover last session, as the company saw its shares rise by nearly 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up a massive 81.4% since Dec 16.
The company has seen no estimate revisions over the past one month, while the Zacks Consensus Estimate remained unchanged over the same period. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Ariad Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Some better ranked med-drugs stocks include Furiex Pharmaceuticals, Inc. (FURX), Jazz Pharmaceuticals Public Limited Company (JAZZ) and Questcor Pharmaceuticals, Inc. (QCOR). All these stocks carry a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
ARIAD PHARMACEUTICALS INC (ARIA): Free Stock Analysis Report
FURIEX PHARMACEUTICALS INC (FURX): Free Stock Analysis Report
JAZZ PHARMACEUTICALS PLC IRELAND (JAZZ): Free Stock Analysis Report
QUESTCOR PHARMACEUTICALS INC (QCOR): Free Stock Analysis Report
Zacks Investment Research
- Health Care Industry
- Finance Trading
- Ariad Pharmaceuticals